PharmaCyte Biotech Stock Forecast - Accumulation Distribution
| PMCB Stock | USD 1.62 0.05 2.99% |
PharmaCyte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast PharmaCyte Biotech stock prices and determine the direction of PharmaCyte Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of PharmaCyte Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
PharmaCyte |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 523.52 | 174.41 |
| Check PharmaCyte Biotech Volatility | Backtest PharmaCyte Biotech | Trend Details |
PharmaCyte Biotech Trading Date Momentum
| On October 14 2024 PharmaCyte Biotech was traded for 1.73 at the closing time. The top price for the day was 1.82 and the lowest listed price was 1.73 . The trading volume for the day was 12.1 K. The trading history from October 14, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.31% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare PharmaCyte Biotech to competition |
Other Forecasting Options for PharmaCyte Biotech
For every potential investor in PharmaCyte, whether a beginner or expert, PharmaCyte Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PharmaCyte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PharmaCyte. Basic forecasting techniques help filter out the noise by identifying PharmaCyte Biotech's price trends.View PharmaCyte Biotech Related Equities
| Risk & Return | Correlation |
PharmaCyte Biotech Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of PharmaCyte Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of PharmaCyte Biotech's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
PharmaCyte Biotech Market Strength Events
Market strength indicators help investors to evaluate how PharmaCyte Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaCyte Biotech shares will generate the highest return on investment. By undertsting and applying PharmaCyte Biotech stock market strength indicators, traders can identify PharmaCyte Biotech entry and exit signals to maximize returns.
| Accumulation Distribution | 884.65 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.65 | |||
| Day Typical Price | 1.64 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.05) |
PharmaCyte Biotech Risk Indicators
The analysis of PharmaCyte Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PharmaCyte Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmacyte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.32 | |||
| Semi Deviation | 4.67 | |||
| Standard Deviation | 5.04 | |||
| Variance | 25.38 | |||
| Downside Variance | 27.14 | |||
| Semi Variance | 21.8 | |||
| Expected Short fall | (4.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PharmaCyte Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PharmaCyte Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmacyte Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmacyte Biotech Stock:Check out Historical Fundamental Analysis of PharmaCyte Biotech to cross-verify your projections. For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. If investors know PharmaCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PharmaCyte Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.64 | Return On Assets (0.05) | Return On Equity 0.4788 |
The market value of PharmaCyte Biotech is measured differently than its book value, which is the value of PharmaCyte that is recorded on the company's balance sheet. Investors also form their own opinion of PharmaCyte Biotech's value that differs from its market value or its book value, called intrinsic value, which is PharmaCyte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PharmaCyte Biotech's market value can be influenced by many factors that don't directly affect PharmaCyte Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PharmaCyte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaCyte Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaCyte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.